O Shaughnessy Asset Management LLC Takes Position in Pro-Dex, Inc. (NASDAQ:PDEX)

O Shaughnessy Asset Management LLC purchased a new stake in Pro-Dex, Inc. (NASDAQ:PDEX - Free Report) in the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund purchased 21,277 shares of the medical instruments supplier's stock, valued at approximately $995,000. O Shaughnessy Asset Management LLC owned approximately 0.65% of Pro-Dex as of its most recent SEC filing.

Several other institutional investors and hedge funds have also bought and sold shares of the company. FMR LLC increased its position in shares of Pro-Dex by 34.9% during the third quarter. FMR LLC now owns 3,973 shares of the medical instruments supplier's stock worth $119,000 after buying an additional 1,028 shares during the period. Bank of New York Mellon Corp purchased a new position in shares of Pro-Dex during the fourth quarter valued at approximately $202,000. Arrowstreet Capital Limited Partnership bought a new stake in shares of Pro-Dex in the 4th quarter worth $255,000. American Century Companies Inc. bought a new position in shares of Pro-Dex during the 4th quarter worth approximately $558,000. Finally, Ritholtz Wealth Management purchased a new position in Pro-Dex in the fourth quarter worth $572,000. Institutional investors own 15.28% of the company's stock.

Insiders Place Their Bets

In other Pro-Dex news, Director Raymond E. Cabillot sold 842 shares of the stock in a transaction that occurred on Friday, March 28th. The shares were sold at an average price of $50.00, for a total value of $42,100.00. Following the transaction, the director now directly owns 278,945 shares in the company, valued at approximately $13,947,250. This trade represents a 0.30 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. In the last quarter, insiders sold 47,953 shares of company stock valued at $2,213,182. Corporate insiders own 47.50% of the company's stock.

Pro-Dex Price Performance

NASDAQ PDEX traded up $2.13 on Friday, reaching $63.23. 55,523 shares of the company's stock traded hands, compared to its average volume of 24,131. The stock has a 50-day simple moving average of $43.65 and a 200 day simple moving average of $42.27. The company has a debt-to-equity ratio of 0.33, a current ratio of 2.58 and a quick ratio of 1.44. Pro-Dex, Inc. has a 12 month low of $16.84 and a 12 month high of $65.87. The stock has a market cap of $206.19 million, a PE ratio of 31.46 and a beta of 0.40.

Pro-Dex (NASDAQ:PDEX - Get Free Report) last posted its quarterly earnings data on Thursday, January 30th. The medical instruments supplier reported $0.61 earnings per share for the quarter, beating the consensus estimate of $0.38 by $0.23. Pro-Dex had a return on equity of 21.68% and a net margin of 11.06%. As a group, research analysts predict that Pro-Dex, Inc. will post 2 earnings per share for the current year.

Wall Street Analyst Weigh In

Separately, StockNews.com downgraded Pro-Dex from a "buy" rating to a "hold" rating in a research note on Wednesday, March 12th.

Pro-Dex Profile

Pro-Dex, Inc designs, develops, manufactures, and sells powered surgical instruments for medical device original equipment manufacturers worldwide. The company offers autoclavable, battery-powered and electric, and multi-function surgical drivers and shavers that are primarily used in the orthopedic, thoracic, and craniomaxillofacial markets.